October 23, 2018 · STOCK Act disclosure
Representative John K. Delaney (Democrat-MD) bought BridgeBio Pharma, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on October 23, 2018 and was disclosed on November 9, 2018 (owner: JT). Members of Congress must report such transactions within 45 days under the STOCK Act.